← back to search

Wenjing Wang

Shihezi University · CN
Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Microbial Natural Products and Biosynthesis, and Sarcoma Diagnosis and Treatment.
h-index
31
citations
2,694
works
177
NIH funding
primary concept
email

Recent publications

The mechanism of EZH2/H3K27me3 downregulating CXCL10 to affect CD8 <sup>+</sup> T cell exhaustion to participate in the transformation from myelodysplastic syndrome to acute myeloid leukaemia
British Journal of Haematology 2025cited by 3position: middledoi
Enhanced efficacy of lung cancer treatment with radiotherapy and immune checkpoint inhibitors without increased pneumonia risk: a systematic review and meta-analysis of randomized controlled trials
Frontiers in Immunology 2025cited by 2position: firstdoi
Caffeic acid inhibits the tumorigenicity of triple-negative breast cancer cells through the FOXO1/FIS pathway
Biomedicine & Pharmacotherapy 2024cited by 19position: lastdoi
IL-37 attenuated HPV induced inflammation and growth of oral epithelial cells via regulating autophagy
Heliyon 2024cited by 4position: middledoi
CyTOF analysis revealed platelet heterogeneity in breast cancer patients received T-DM1 treatment
Clinical Immunology 2024cited by 2position: lastdoi
A causal effects of gut microbiota in the development of migraine
The Journal of Headache and Pain 2023cited by 47position: middledoi
Gastric Cancer Harboring an ERBB3 Mutation Treated with a Pyrotinib–Irinotecan Combo: A Case Study
OncoTargets and Therapy 2021cited by 6position: middledoi
Response to crizotinib in a patient with <i>MET‐</i>amplified hepatocellular carcinoma
Hepatology Research 2021cited by 5position: middledoi
PI3K-AKT-mTOR pathway alterations in advanced NSCLC patients after progression on EGFR-TKI and clinical response to EGFR-TKI plus everolimus combination therapy
Translational Lung Cancer Research 2020cited by 88position: middledoi
Baseline immunity and impact of chemotherapy on immune microenvironment in cervical cancer
British Journal of Cancer 2020cited by 66position: middledoi
EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer
BMC Cancer 2019cited by 118position: middledoi
Mutation Variants and Co-Mutations as Genomic Modifiers of Response to Afatinib in <i>HER2</i>-Mutant Lung Adenocarcinoma
The Oncologist 2019cited by 64position: middledoi
Notch family gene mutations associate with high tumor mutational burden in diverse cancers.
Journal of Clinical Oncology 2019cited by 2position: middledoi
Niclosamide ethanolamine improves diabetes and diabetic kidney disease in mice.
PubMed 2018cited by 22position: middle
Hydrogen coadministration slows the development of COPD-like lung disease in a cigarette smoke-induced rat model
International Journal of COPD 2017cited by 43position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Wenfeng Fang · Guangdong Provincial People's Hospital3 papers (2019–2020)K. Wang · Shandong University2 papers (2019–2020)Jiadi Gan · Sichuan University2 papers (2019–2020) · 2 papers (2024–2024)Yuefeng Shang · Harbin Medical University2 papers (2024–2024)Yunpeng Yang · CSPC Pharmaceutical Group2 papers (2019–2020)Yuheng Pang · Harbin Medical University2 papers (2024–2024)Liujia Chan · Harbin Medical University2 papers (2024–2024)Yihua Huang · Sun Yat-sen University2 papers (2019–2020)Minghui Wang · Sun Yat-sen University2 papers (2019–2019)Kai Wang · Anyang Hospital of Traditional Chinese Medicine1 papers (2019–2019)Kai Wang · Zhejiang University1 papers (2019–2019)Xiaoyu Liu · First Affiliated Hospital of Hebei Medical University1 papers (2017–2017)Chunlei Zhang · Guangzhou University of Chinese Medicine1 papers (2018–2018) · 1 papers (2019–2019)Ning Liu · The University of Adelaide1 papers (2024–2024)Lihua Qiu · Soochow University1 papers (2020–2020)Jiejun Cheng · Anhui Medical University1 papers (2020–2020)Qian Deng · Yale Cancer Center1 papers (2024–2024)Songhui Zhao · Jilin University1 papers (2019–2019)